Description
PT-141 research peptide
PT-141, also called bremelanotide, is a cyclic heptapeptide melanocortin receptor agonist derived from Melanotan II. It acts mainly at MC4R in the central nervous system and is studied in neuroscience research.
Product details
| Compound | PT-141 (bremelanotide) |
|---|---|
| Class | Melanocortin receptor agonist (cyclic heptapeptide) |
| Format | Lyophilised peptide vial |
| Labelling | Compound name and strength on every container |
What PT-141 research has examined
- Melanocortin signalling: MC3R and MC4R agonism in the central nervous system.
- Neuroendocrine research: central pathways studied in clinical trials.
- Analogue development: its derivation from Melanotan II.
Research interest does not establish a proven effect in humans.
Regulatory status
Licensed medicines containing this active ingredient are prescription-only products made by authorised manufacturers. The material sold here is a research chemical, not a licensed medicine, and is not approved for any use in humans.
Storage and handling
Store lyophilised vials cold, dry and away from light. Reconstitute with a suitable sterile diluent under aseptic conditions and keep solutions refrigerated. See our peptide reconstitution guide.
Related research products
Adamax / Adalank Combo Pack · Healing Research Bundle · Turn Back Time Bundle · All peptides
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.